Evidence map›Paper›PMID 21604810›Full record

ArticleACS nano2011

A boost for the emerging field of RNA nanotechnology.

Girish C Shukla, Farzin Haque, Yitzhak Tor, L Marcus Wilhelmsson, Jean-Jacques Toulmé, Hervé Isambert, Peixuan Guo, John J Rossi, Scott A Tenenbaum, Bruce A Shapiro

Open access · bronzeAbstract readConference Proceedings
In one paragraph

Article in ACS nano, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 107 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Construction of RNA nanotubes.Nano research · 2019
    Article
  12. Review
  13. Article
  14. Review
  15. Dynamic Behavior of RNA Nanoparticles Analyzed by AFM on a Mica/Air Interface.Langmuir : the ACS journal of surfaces and colloids · 2018
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 3 countries.

Girish C ShuklaCenter for Gene Regulation in Health and Disease, Department of Biological Sciences, Cleveland State University, Cleveland, Ohio 44115, United States.
Farzin Haque
Yitzhak Tor
L Marcus Wilhelmsson
Jean-Jacques Toulmé
Hervé Isambert
Peixuan Guo
John J Rossi
Scott A Tenenbaum
Bruce A Shapiro
University of Cincinnati · USBeckman Research InstituteCenter for Cancer Research · USChalmers University of Technology · SECleveland State University · USInstitut Curie · FRUniversité de Bordeaux · FRUniversity at Albany, State University of New York · USUniversity of California, San Diego · US

Funding

Computational RNA NanodesignZIABC011061 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SHAPIRO, BRUCE · 2009 to 2021
$12.3M
Phi29 DNA-Packaging Motor for NanomedicinePN2EY018230 · NEI · UNIVERSITY OF CINCINNATI · PI GUO, PEIXUAN · 2006 to 2009
$4.6M
Nanotube and nanogold to gear phi29 DNA packaging motorR01EB003730 · NIBIB · UNIVERSITY OF KENTUCKY · PI GUO, PEIXUAN · 2004 to 2012
$2.3M
RNA Nanotechnology in Cancer TherapyU01CA151648 · NCI · UNIVERSITY OF KENTUCKY · PI GUO, PEIXUAN, LI, HENRY · 2010 to 2014
$2.1M
STRUCTURE/FUNCTION OF PHI29 HEXAMERIC PRNAR01GM059944 · NIGMS · UNIVERSITY OF CINCINNATI · PI GUO, PEIXUAN · 1999 to 2009
$1.9M
Intramural NIH HHSNCI NIH HHS CA151648NCI NIH HHS U01 CA151648NEI NIH HHS PN2 EY 018230NEI NIH HHS PN2 EY018230NIBIB NIH HHS EB003730NIBIB NIH HHS R01 EB003730NIGMS NIH HHS GM059944NIGMS NIH HHS R01 GM059944
6 · The paper itself

Abstract

This Nano Focus article highlights recent advances in RNA nanotechnology as presented at the First International Conference of RNA Nanotechnology and Therapeutics, which took place in Cleveland, OH, USA (October 23-25, 2010) ( http://www.eng.uc.edu/nanomedicine/RNA2010/ ), chaired by Peixuan Guo and co-chaired by David Rueda and Scott Tenenbaum. The conference was the first of its kind to bring together more than 30 invited speakers in the frontier of RNA nanotechnology from France, Sweden, South Korea, China, and throughout the United States to discuss RNA nanotechnology and its applications. It provided a platform for researchers from academia, government, and the pharmaceutical industry to share existing knowledge, vision, technology, and challenges in the field and promoted collaborations among researchers interested in advancing this emerging scientific discipline. The meeting covered a range of topics, including biophysical and single-molecule approaches for characterization of RNA nanostructures; structure studies on RNA nanoparticles by chemical or biochemical approaches, computation, prediction, and modeling of RNA nanoparticle structures; methods for the assembly of RNA nanoparticles; chemistry for RNA synthesis, conjugation, and labeling; and application of RNA nanoparticles in therapeutics. A special invited talk on the well-established principles of DNA nanotechnology was arranged to provide models for RNA nanotechnology. An Administrator from National Institutes of Health (NIH) National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer discussed the current nanocancer research directions and future funding opportunities at NCI. As indicated by the feedback received from the invited speakers and the meeting participants, this meeting was extremely successful, exciting, and informative, covering many groundbreaking findings, pioneering ideas, and novel discoveries.

Indexed as

ForecastingGenetic TherapyNanomedicineNanostructuresRNARNA

Identifiers

PMID21604810
PMCPMC3102291
OpenAlexW2142744600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.